| mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-06 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-06 |
| mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
1e-05 |
| mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
0.24 |
2e-05 |
| mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
| mRNA |
BIX02189 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
3e-05 |
| mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
| mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.21 |
0.0001 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |